Steven Cohen's PALI Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 5.25 M shares of Palisade Bio, Inc. (PALI) worth $10.98 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in PALI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 4.84 M shares. Largest reduction occurred in Q1 2026, reducing 10.08 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Palisade Bio (PALI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Palisade Bio (PALI) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4.84 M | Add 1175.80% | 5.25 M | $2.09 |
| Q1 2026 | -10.08 M | Reduce 96.08% | 411,772 | $1.75 |
| Q4 2025 | +10.5 M | New Buy | 10.5 M | $2.35 |
Steven Cohen's Palisade Bio Investment FAQs
Steven Cohen first purchased Palisade Bio, Inc. (PALI) in Q4 2025, acquiring 10,495,252 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Palisade Bio, Inc. (PALI) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Palisade Bio, Inc. (PALI) was in Q4 2025, adding 10,495,252 shares worth $24.66 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 5,253,403 shares of Palisade Bio, Inc. (PALI), valued at approximately $10.98 M.
As of the Q2 2026 filing, Palisade Bio, Inc. (PALI) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Palisade Bio, Inc. (PALI) was 10,495,252 shares, as reported at the end of Q4 2025.